Showing results (81-90 of 206) with videos related to

Sort By:
Pageof 21
Human Molecular Genetics|May 25, 2002
Promoter switch: a novel mechanism causing biallelic PEG1/MEST expression in invasive breast cancerInge Søkilde Pedersen, Peter Dervan, Alo McGoldrick, et al.
Annals of the Rheumatic Diseases|May 7, 2010
Profound invariant natural killer T-cell deficiency in inflammatory arthritisSusan J Tudhope, Alexei von Delwig, Jane Falconer, et al.
Arthritis and Rheumatism|February 2, 2008
Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomesAlice R Lorenzi, Alexandra M Clarke, Tom Wooldridge, et al.
Digestive Diseases and Sciences|August 21, 2020
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical TrialsRemo Panaccione, John D Isaacs, Lea Ann Chen, et al.
Annals of the Rheumatic Diseases|June 2, 2016
High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohortMeghna Jani, John D Isaacs, Ann W Morgan, et al.
Arthritis and Rheumatism|November 10, 2010
Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven lociDarren Plant, John Bowes, Catherine Potter, et al.
Annals of the Rheumatic Diseases|April 26, 2012
A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative diseaseArthur G Pratt, Daniel C Swan, Sarah Richardson, et al.
Rheumatology (Oxford, England)|January 19, 2017
The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohortSamantha Louise Smith, Darren Plant, Stephen Eyre, et al.
Rheumatology (Oxford, England)|August 28, 2016
Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levelsMeghna Jani, John D Isaacs, Ann W Morgan, et al.
Human Molecular Genetics|August 21, 2008
Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritisJames R Maxwell, Catherine Potter, Kimme L Hyrich, et al.
Pageof 21